Dysregulated production of interferon-γ, interleukin-4 and interleukin- 6 in early tuberculosis patients in response to antigen 85B of Mycobacterium tuberculosis

Scandinavian Journal of Immunology

Volumn 51, Issue 2, 2000, Pages 209-217

  Jo, E K ^a   Kim, H J ^a   Lim, J H ^a   Min, D ^a   Song, Y ^a   Song, C H ^a   Paik, T H ^b   Suhr, J W ^c   Park, J K ^a  

^a Chungnam National University   (South Korea)

^b Konyang University   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 6; TUBERCULIN; TUBERCULOSTATIC AGENT;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFORMATION; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE; TUBERCULOSIS;

ACYLTRANSFERASES; ANTIGENS, BACTERIAL; ANTIGENS, CD14; BACTERIAL PROTEINS; CELL DIVISION; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTES; TUBERCULOSIS;

EID: 0033952141     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00663.x     Document Type: Article

References (42)

1. 1 Kaufmann SHE. Immunity to intracellular bacteria. Annu Rev Immunol 1993;11:129-63.
2. 2 Fulton SA, Johnsen JM, Wolf SF, Sieburth DS, Boom WH. Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: Role of phagocytosis. Infect Immun 1996;64:2523-31.
3. 3 Sato K, Akaki T, Tomioka H. Differential potentiation of anti-mycobacterial activity and reactive nitrogen intermediate-producing ability of murine peritoneal macrophages activated by interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha). Clin Exp Immunol 1998;112:63-8.
4. 4 Appelberg R. Protective role of interferon gamma, tumor necrosis factor alpha and interleukin-6 in Mycobacterium tuberculosis and M. avium infections. Immunobiology 1994;191:520-5.
5. + T cells. Annu Rev Immunol 1994;12:635-73.
6. 6 Russo DM, Chakrabarti P, Burns JM Jr. Naive human T cells develop into Th1 or Th0 effectors and exhibit cytotoxicity early after stimulation with Leishmania-infected macrophages. J Infect Dis 1998;177:1345-51.
7. 7 Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon-γ gene-disrupted mice. J Exp Med 1993;178:2243-9.
8. 8 Flynn JA, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for IFN-γ in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993;178:2249-55.
9. 9 Robinson DS, Ying S, Taylor IK et al. Evidence for a Th1-like bronchoalveolar T-cell subset and predominance of interferon-gamma gene activation in pulmonary tuberculosis. Am J Respir Crit Care Med 1994;149:989-93.
10. 10 Cooper AM, Roberts AD, Rhoades ER, Callahan JE, Getzy DM, Orme IM. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 1995;84: 423-32.
11. 2 production and anti-leishmanial capacity of human cultured monocytes mediated by IFN-γ. J Immunol 1989;144:625-33.
12. 12 Oswald IP, Gazzinelli RT, Sher A, James SL. IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. J Immunol 1992;148:3578-82.
13. 13 Lin Y, Zhang M, Hofman FM, Gong J, Barnes PF. Absence of a prominent Th2 cytokine response in human tuberculosis. Infect Immun 1996;64:1351-6.
14. 14 Wallis RS, Amir TM, Ellner JJ. Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte Western blot. Proc Natl Acad Sci USA 1990;87:3348-52.
15. 15 Denis M. Killing of Mycobacterium tuberculosis within human monocytes: activation by cytokines and calcitriol. Clin Exp Immunol 1991;84:200-6.
16. 16 Law K, Weiden M, Harkin T, Tchou-Wong K, Chi C, Rom WN. Increased release of interleukin-1β, interleukin-6, and tumor necrosis factor-α by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. Am J Respir Crit Care Med 1996;153: 799-804.
17. 17 Flesch IEA, Kaufmann SHE. Stimulation of antibacterial macrophage activities by B-cell stimulatory factor 2 (Interleukin-6). Infect Immun 1990;58:269-71.
18. 18 Denis M, Gregg EO. Recombinant tumour necrosis factor-alpha decreases whereas recombinant interleukin-6 increases growth of a virulent strain of Mycobacterium avium in human macrophages. Immunology 1990;71:139-41.
19. 19 Belisle JT, Vissa VD, Sievert T, Takayama K, Brennan PJ, Basra GS. Role of the major antigen of Mycobacterium tuberculosis in cell wall biosynthesis. Science 1997;276:1420-2.
20. 20 Orme I. Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance, in mice inoculated with killed mycobacterial vaccines. Infect Immun 1988;56:3310-2.
21. 21 Kamath AT, Feng CG, MacDonald M, Briscoe H, Britton WJ. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect Immun 1999;67: 1702-7.
22. 22 Lim J-H, Park J-K, Jo E-K et al. Purification and immunoreactivity of three components from the 30/32-kilodalton antigen 85 complex in Mycobacterium tuberculosis. Infect Immun 1999;67:6181-90.
23. 23 Sambroock J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd edn. New York: Cold Spring Harbor Laboratory, 1989.
24. 24 Vikingsson A, Pederson K, Muller D. Enumeration of IFN-gamma producing lymphocytes by flow cytometry and correlation with quantitative measurement of IFN-gamma. J Immunol Methods 1994;173:219-28.
25. 25 Montani MSG, Gallo FD, Lombardi G et al. Limiting dilution analysis of T cell unresponsiveness to mycobacteria in advanced disseminated tuberculosis. Med Microb Immunol 1989; 178:235-44.
26. 26 Ellner JJ. Regulation of the human cellular immune response to Mycobacterium tuberculosis. The mechanism of selective depression of the response to PPD. Bull Int Union Tuber Lung Dis 1991; 66:129-32.
27. 27 Zhang M, Lin Y, Iyer DV, Gong J, Abrams JS, Barnes PF. T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun 1995;63:3231-4.
28. 28 Torres M, Herrera T, Villareal H, Rich EA, Sada E. Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of Mycobacterium tuberculosis. Infect Immun 1998;66:176-80.
29. 29 Havlir DV, van der Kuyp F, Duffy E, Marshall R, Hom D, Ellner JJ. A 19-year follow-up of tuberculin reactors: Assessment of skin test reactivity and in vitro lymphocyte responses. Chest 1991;99: 1172-6.
30. 30 Barnes PF, Modlin RL, Ellner JJ. T-cell responses and cytokines. In: Bloom BR, eds. Tuberculosis: Pathogenesis, Protection, and Control. Washington DC, ASM Press, 1994: 417-30.
31. 31 Havlir DV, Wallis RS, Boom WH, Daniel TM, Chervenak K, Ellner JJ. Human immune response to Mycobacterium tuberculosis antigens. Infect Immun 1991;59:665-70.
32. 32 Huygen K, Van Vooren JP, Turneer M, Bosmans R, Dierckx P, De Bruyn J. Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32-kDa mycobacterial protein antigen (P32) in patients with active tuberculosis. Scand J Immunol 1988;27:187-94.
33. 33 Bentley-Hibbert SI, Quan X, Newman T, Huygen K, Godfrey HP. Pathophysiology of antigen 85 in patients with active tuberculosis: Antigen 85 circulates as complexes with fibronectin and immunoglobulin G. Infect Immun 1999;67:581-8.
34. 34 Turneer M, Van Vooren JP, De Bruyn J, Serruys E, Dierckx P, Yernault JC. Human immune response in human tuberculosis: Immunoglobulins G, A, and M directed against the purified P32 protein antigen of Mycobacterium bovis bacillus Calmette-Guérin. J Clin Microbiol 1988;26:1714-9.
35. 35 Jung T, Schauer U, HeusSeries C et al. Detection of intracellular cytokines by flow cytometry. J Immunol Methods 1993;159: 197-205.
36. 36 Ferrick DA, Schrenzel MD, Mulvania T et al. Differential production of interferon-γ and interleukin-4 in response to Th1-and Th2-stimulating pathogens by γδ T cells in vivo. Nature 1995;373: 255-7.
37. + T cells from normal and immunodeficient donors using directly conjugated anti-cytokine antibodies and three-colour flow cytometry. Clin Exp Immunol 1996;105:517-22.
38. 38 Suzuki Y, Orellana MA, Schreiber RD, Reminton JS. Interferon gamma: The major mediator of resistance against Toxoplasma gondii. Science 1987;240:516-8.
39. 39 Taha RA, Kotsimbos TC, Song Y-L, Menzies D, Hamid Q. IFN-γ and IL-12 are increased in active compared with inactive tuberculosis. Am J Respir Crit Care Med 1997; 155:1135-9.
40. 40 Surcel MH, Troye-Blomberg M, Paulie S et al. Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 1994; 81:171-6.
41. 41 Orme IM, Roberts AD, Griffin JP, Atrams JS. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol 1993;151:518-25.
42. 42 Ogawa T, Uchida H, Kusumoto Y, Mori Y, Yamamura Y, Hamaa Y. Increase in tumor necrosis factor alpha-and interleukin-6-secreting cells in peripheral blood mononuclear cells from subjects infected with Mycobacterium tuberculosis. Infect Immun 1991;59:3021-5.